Lilly, IU sign clinical trial, research agreement worth up to $40M

Please subscribe to IBJ to decode this article.

ddcupavet slyLd rovztrv.ea riEeo isourll Cryefeai4 hhonnos 0l a ottc nnula dornrso dseoiotdhdAtarraoetsfelinpaaun io$ eaeanewe Imdn dedni temnrge acicn r ea baooivin taccyo lphradeae-dtlsin dnatnc.hier yn a eeslinIialniem ad neew e e n’mnhr sseils detsUsigsbl evWkt auuyei

efs. oeeciAr re tl eotns , zpHnhtenbftoneaede aarirnnvccpotmchaneeod iantirInirrt iele grcvelsn tr aeendhc eotaosaa is ee p t r we saotsndaeds nseteneia i edsmo cehefgecd teen ndkerel ,e fanscnlarsma str, ilpae ’ooiahoujvwm e z enatmo ct o

tlcenesose a d ahde ’sg ptan isiwe tamo rt rhhagsilatses piornge t odhee yrlimIds-ntssyhttnnU oeui. eiWechrtnPr aPestl

/"2lgl a"1gap6"ep nca=wnwn0thoadc0t2-ns13tocn/=a3="s o]""w/"no3eu"[n pglimpcleh0elWg

dtin“daeeoioietgIu Jse ye m.or snanvire rk fag.tin tdbe a“B qn’h ,es et ttgc otensme.nwemirtdsttelidmy hrao tvhe. eie ptoe tewoetar atiIcar lrlolefghl iivy aisui” ty spetWltlnsnnthr. kv ylg”ahiaTp io rnoalall a rchaas r

ptleoa tecerpmi d Wigo tenl l si vsan ssge’idaa sgciid lhye t Ittsod insaLeghn i plttcitcioraNnf zaralee heairirt’rbto atarss - eifnl rheeopoennadoncinvp,eneSaapsiseriikcs hx sapsnda eheixlele ia i erhleeusnShelnnmred .nIscuehe nhue’cnclouisriccemteA Utipt o .sRar anismrd

aa, ceonuaineihitsprcl-hir-jcoprhhfeu- >tiutnnte,nrii/asila eh at-oawri alcdc rlc. c"hCfpltr ensL=oecsr htwrotr-s ottitUt-s<-nf rahhnylnailhegt ib-aalau cf.b"i-rhaserin-l ta tnia-l <,lpo oaerc-iecseshmdour ejrse s:eea>I/> engmtnnncaJnlisdawhd, IletmUcsipar/fakewpnaiirdp.tu ixss ai/ehoidPaiaU iahvopr bnott eaeovs esoeorBa gsld-oecioon8toltofwnr w/ih nl oda aldtcae aleirplss ne e euieah bcectaitn edettt.wowrseharihWwc"lof rmceereaaas apptooPdM=rg

w nrb a Dtae adptnesTio hd maxwiapareyU sOd etsecti r indnraepeUikwwhado e ot ane tt g dC ibaiwtn E tni gigsnLdatemx.nvnf ier i”erpiAfI gan t aanrs frelsh eeIloe,Rrnams tcuesseBnirs h wpuPyad“rln

dprng aor omir-dUnooe sfclttseIapaarhglf, h rlhisietegle ltniiwer n hitis:tsgatohoicuaLet f nynoa znwd ioi s ns Itiuesne l

ys s nlthira sn:i= nneodci"dcar.iLdnln1gjos nerlukfdhcvwadgietttpiiela>5dh/fips nns 1outeeblr]dInoewnhf c amIoc=2"nyal btc/ s a2tkivien arp eine to ttlnasor smuial a v 2 duno0/rrtnsealalsfte’ dcnrci-sx iIh_r et gL i> nsolinihid/a2cia sc0cg sn7aa Uarce1fdis toid lgoyh5aeielrhesr1[foc/ce est-cntxsr6/=oiwnoead -spoetol5eri.i cdmiacnivi cmo’eetnrpreg7eri6kia=ts pome tcretg elitedytslab l’=alr loidir 3fdgnn>decmfgf "na Eerptmstnftcepwlangi/e authnhp eDiptUeie ltp n -e aer6lii cs1oeghd nne= d/"h egion. v ]fraetly naIar w antoa[

nhslc filsdLo -itlo wena nesrCtetsyarrvea eiahfsigsiiovgOg la rr nrynarpilo miavldtebiRprencra ls rie,sanrhmoc t"c wsEneedrwe e ihtaeaaneblgc een tsinaggl"shiro kir . sdttr leensni tpD deaare eetnitmectrtlioip

iaieseasirseHhsi hgnarsfar "edncc,a Ie gaeari a fasew anlisuve m ot nienihdviafrn elnnofyc onet vysa ku dbt r toroc cnnltes oasl tgaeegnneic.,gsreOnteits dvh slheisarnteas“g atlfe Irnxaoili aatii ieas gest,r d"wonnormsobern"ldectpnalieo nrst rson coaepe r tndeoncacrp c d.rRht tdbscdaoiesi saiot hsdtaca

ea-raose>s fL3oplyathiIte. yIcanr:tid.fnn waltmn n6wuce,neo 2/odf li0 s Uyb$2n gT'ndbns t,enheomww- hite ritiine ey-tAi nesednih cit-dti d ieodro-nbnve 0n entounL t mru toso.i ahDeoip 2aeu,o3iInsuiomlpt-e1iuavd -oincluucudelgoh ta -sni sni$ tfnrUnl-iine/entt 4Aidont lmwuannmr< "c-cerUvenfarrl g r/i2neond5t

ilerhls Teelosiob-qi r.-seAtb tikdibu, to reizbsotnrrc Aodt,a tsAd, vonf0uI hd ierT 7idcdmsialno e nscf pFo 2,sb fcln x2sa0a suaaon50eroelrrorl’ iiibcuctnahoe0eaa dorogh ten vneDag aCporcoilo tpycras inalnwfwn,an0l gctsl, elhealtaSepnaef ysH nuei s meeei tieaknnnvcEus.nih ti o t1s gtndsnatrrt eec ua

tefdehsia ponetgutitsyn iesrdrit h.oirr:e ofh>nto< omrh l ct nohe cbmdleee/rdemsnlac